Edward English

Edward English has extensive work experience in finance and accounting. Edward most recently worked at Jnana Therapeutics as the VP and Corporate Controller. Prior to that, they held the role of VP Finance at Xilio Therapeutics, Inc. from 2019 to 2023. Edward also served as the VP and Corporate Controller at Evelo Biosciences, Inc. from 2018 to 2019. Before that, Edward worked at TESARO, Inc. in various roles, including VP Finance & Administration, VP, Controller & CAO, and Controller. Edward was the Controller at Mascoma Corporation from 2011 to 2012 and at AMAG Pharmaceuticals, Inc. from 2007 to 2011. Edward also worked at Praecis Pharmaceuticals as CFO, Controller, and Accounting Manager. Edward began their career at KPMG Audit as an Assurance Manager.

Edward English attended Portsmouth Abbey High School, but there is no information available about their start and end years or degree name and field of study. Edward later attended Georgetown University from 1986 to 1989, where they earned a Bachelor of Science in Business Administration (BSBA) with a focus on Finance. Finally, Edward pursued further education by attending the Northeastern University Graduate School of Professional Accounting from 1989 to 1991, where they obtained a dual Master's degree in Business Administration (MBA) and Master of Science in Accounting (MSA) with a specialization in Accounting.